Global Patterns of Incidence and Mortality in Lung Cancer

Doğan, Nurhan; DOĞAN, İsmet

doi:10.14744/ejmo.2018.0025

Global Patterns of Incidence and Mortality in Lung Cancer

Nurhan DOĞAN, (Afyonkarahisar Sağlık Bilimleri Üniversitesi)

İsmet DOĞAN (Afyonkarahisar Sağlık Bilimleri Üniversitesi)

Eurasian Journal of Medicine and Oncology

3 0

Yıl: 2019 Cilt: 3 Sayı: 1 Sayfa Aralığı: 28 - 32 Metin Dili: İngilizce DOI: 10.14744/ejmo.2018.0025 İndeks Tarihi: 21-04-2020

Global Patterns of Incidence and Mortality in Lung Cancer

Öz:

Objectives: Lung cancer has been the leading cause of cancer mortality, and its incidence is growing throughoutthe world. This study aims to compare the distribution of the six World Health Organization by configural frequencyanalysis (CFA).Methods: The National data (GLOBOCAN 2012) were included in the analysis. Data were analyzed by CFA which is usedfor the analysis of multiway contingency tables.Results: In Africa, East Mediterranean, Europe, and Southeast Asia, lung cancer incident cases were observed to behigher than expected. Under the years <70, in Africa, East Mediterranean, Europe, and Southeast Asia, lung cancer mortality is significantly underrepresented and therefore antitypes. Here, lung cancer mortality was observed lower thanexpected. In the more developed regions, lung cancer incident cases and mortality were significantly overrepresentedin almost all age groups in both male (years <55) and female, but in the less developed regions, it was significantlyunderrepresented in almost all age groups.Conclusion: The majority of the global lung cancer burden occurred in the more developed countries. If the currentsituation remains unchanged, incidence and mortality may continue to increase.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Brown WR, Ahnen DJ. The international health care burden of cancers of the gastrointestinal tract and liver. Cancer Res Front 2014;1:1–9.
2. Stewart BW, Wild CP, editors. World Cancer Report. Lyon, France: International Agency for Research on Cancer; 2014.
3. American Cancer Society. Global Cancer Facts and Figures. 3rd ed. Atlanta: American Cancer Society; 2015.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
5. Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: Geographical distribution and secular trends. J Thorac Oncol 2008;3:819–31.
6. GLOBOCAN 2012. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Available at: http://www. globocan.iarc.fr/Default.aspx.
7. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 1. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http:// www.globocan.iarc.fr.
8. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133–45.
9. World Health Organization (WHO). Health Statistics and İnformation Systems, Definition of Region Groupings. Available at: http://www.who.int/healthinfo/global_burden_disease/definition_regions/en. Accessed Dec 20, 2018.
10. Lars R. Bergmana1, Wångby M. The person-oriented approach: A short theoretical and practical guide. Eesti Haridusteaduste Ajakiri 2014;2:29–49.
11. von Eye A. Introduction to Configural Frequency Analysis. Canada: Cambridge University Press; 1990. p. 3–39.
12. von Eye A. The odds favor antitypes: A comparison of tests for the identification of configural types and antitypes. Methods Psychol Res 2002;7:1–29.
13. von Eye A, Pena EG. Configural frequency analysis of large sparse cross-classifications. Psychol Sci 2005;47:356–76.
14. Stemmler M. Person-Centered Methods: CFA and Other Methods for The Analysis of Contingency Tables. Switzerland: Springer International Publishing; 2014. p. 19–23.
15. Holm, S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65–70. 16. ArcGIS 10.3 for Desktop, Esri İnc. Available at: http://www.esri. com.
17. American Cancer Society. Cancer in Africa. Atlanta; 2011.
18. Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res 2015;4:327–38.
19. Martiniuk A, Lee CM, Woodward M, Huxley R. Burden of lung cancer deaths due to smoking for men and women in the WHO western pacific and South East Asian regions. Asian Pac J Cancer Prev 2010;11:67–72.
20. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975- 2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672–94.
21. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: Epidemiology, etiology, and prevention. Clin Chest Med 2011;32:605–44.
22. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30.
23. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
24. Didkowska J, Wojciechowska U, Mańczuk M, Łobaszewski J. Lung cancer epidemiology: Contemporary and future challenges worldwide. Ann Transl Med 2016;4:150.
25. Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, et al. Lung cancer mortality in European women: Trends and predictions. Lung Cancer 2012;78:171–8.

APA	Doğan N, DOĞAN İ (2019). Global Patterns of Incidence and Mortality in Lung Cancer. , 28 - 32. 10.14744/ejmo.2018.0025
Chicago	Doğan Nurhan,DOĞAN İsmet Global Patterns of Incidence and Mortality in Lung Cancer. (2019): 28 - 32. 10.14744/ejmo.2018.0025
MLA	Doğan Nurhan,DOĞAN İsmet Global Patterns of Incidence and Mortality in Lung Cancer. , 2019, ss.28 - 32. 10.14744/ejmo.2018.0025
AMA	Doğan N,DOĞAN İ Global Patterns of Incidence and Mortality in Lung Cancer. . 2019; 28 - 32. 10.14744/ejmo.2018.0025
Vancouver	Doğan N,DOĞAN İ Global Patterns of Incidence and Mortality in Lung Cancer. . 2019; 28 - 32. 10.14744/ejmo.2018.0025
IEEE	Doğan N,DOĞAN İ "Global Patterns of Incidence and Mortality in Lung Cancer." , ss.28 - 32, 2019. 10.14744/ejmo.2018.0025
ISNAD	Doğan, Nurhan - DOĞAN, İsmet. "Global Patterns of Incidence and Mortality in Lung Cancer". (2019), 28-32. https://doi.org/10.14744/ejmo.2018.0025

APA	Doğan N, DOĞAN İ (2019). Global Patterns of Incidence and Mortality in Lung Cancer. Eurasian Journal of Medicine and Oncology, 3(1), 28 - 32. 10.14744/ejmo.2018.0025
Chicago	Doğan Nurhan,DOĞAN İsmet Global Patterns of Incidence and Mortality in Lung Cancer. Eurasian Journal of Medicine and Oncology 3, no.1 (2019): 28 - 32. 10.14744/ejmo.2018.0025
MLA	Doğan Nurhan,DOĞAN İsmet Global Patterns of Incidence and Mortality in Lung Cancer. Eurasian Journal of Medicine and Oncology, vol.3, no.1, 2019, ss.28 - 32. 10.14744/ejmo.2018.0025
AMA	Doğan N,DOĞAN İ Global Patterns of Incidence and Mortality in Lung Cancer. Eurasian Journal of Medicine and Oncology. 2019; 3(1): 28 - 32. 10.14744/ejmo.2018.0025
Vancouver	Doğan N,DOĞAN İ Global Patterns of Incidence and Mortality in Lung Cancer. Eurasian Journal of Medicine and Oncology. 2019; 3(1): 28 - 32. 10.14744/ejmo.2018.0025
IEEE	Doğan N,DOĞAN İ "Global Patterns of Incidence and Mortality in Lung Cancer." Eurasian Journal of Medicine and Oncology, 3, ss.28 - 32, 2019. 10.14744/ejmo.2018.0025
ISNAD	Doğan, Nurhan - DOĞAN, İsmet. "Global Patterns of Incidence and Mortality in Lung Cancer". Eurasian Journal of Medicine and Oncology 3/1 (2019), 28-32. https://doi.org/10.14744/ejmo.2018.0025